Literature DB >> 7513294

Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens.

J F Culard1, M Desgeorges, P Costa, M Laussel, G Razakatzara, H Navratil, J Demaille, M Claustres.   

Abstract

Several recent studies have demonstrated the presence of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in healthy males with infertility caused by congenital absence of the vas deferens (CBAVD), previously recognized as an idiopathic genetic condition distinct from CF. In order to document further the genetic commonality of these two disorders, we undertook a double screening of the entire coding and flanking sequences of the CFTR gene, by using single-strand conformational polymorphism analysis and denaturing gradient gel electrophoresis in 12 unrelated infertile men with abnormalities of the vas deferens and/or epididymis. This strategy allowed us to identify 11 DNA sequence alterations considered as CF-causing mutations and several variations. Despite this double analysis, only two patients out of eight with CBAVD could be demonstrated as compound heterozygotes for CF mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513294     DOI: 10.1007/bf00201678

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

Authors:  B S Kerem; J Zielenski; D Markiewicz; D Bozon; E Gazit; J Yahav; D Kennedy; J R Riordan; F S Collins; J M Rommens
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences.

Authors:  P Gasparini; V Nunes; A Savoia; M Dognini; N Morral; A Gaona; A Bonizzato; M Chillon; F Sangiuolo; G Novelli
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

3.  Rapid nonradioactive detection of the major cystic fibrosis mutation.

Authors:  J Rommens; B S Kerem; W Greer; P Chang; L C Tsui; P Ray
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

4.  Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues.

Authors:  E F Tizzano; D Chitayat; M Buchwald
Journal:  Hum Mol Genet       Date:  1993-03       Impact factor: 6.150

5.  High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens.

Authors:  R Gervais; V Dumur; J M Rigot; J J Lafitte; P Roussel; M Claustres; J Demaille
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

6.  Congenital absence of the vas deferens. The fertilizing capacity of human epididymal sperm.

Authors:  S J Silber; T Ord; J Balmaceda; P Patrizio; R H Asch
Journal:  N Engl J Med       Date:  1990-12-27       Impact factor: 91.245

7.  CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents.

Authors:  A E Trezise; C C Linder; D Grieger; E W Thompson; H Meunier; M D Griswold; M Buchwald
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

8.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis.

Authors:  A Anguiano; R D Oates; J A Amos; M Dean; B Gerrard; C Stewart; T A Maher; M B White; A Milunsky
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

9.  Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France.

Authors:  M Claustres; M Laussel; M Desgeorges; M Giansily; J F Culard; G Razakatsara; J Demaille
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

10.  Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions.

Authors:  P Fanen; N Ghanem; M Vidaud; C Besmond; J Martin; B Costes; F Plassa; M Goossens
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

View more
  11 in total

1.  Identification of a novel mutation in CFTR gene exon 8 (L375F) in a CUAVD phenotype.

Authors:  P Jézéquel; B Chauvel; A Le Treut; J Y Le Gall; V David; D Le Lannou; M Blayau
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

2.  CFTR gene variant for patients with congenital absence of vas deferens.

Authors:  J Zielenski; P Patrizio; M Corey; B Handelin; D Markiewicz; R Asch; L C Tsui
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

3.  The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Authors:  N Rave-Harel; E Kerem; M Nissim-Rafinia; I Madjar; R Goshen; A Augarten; A Rahat; A Hurwitz; A Darvasi; B Kerem
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

4.  Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.

Authors:  Michael Wilschanski; Annie Dupuis; Lynda Ellis; Keith Jarvi; Julian Zielenski; Elizabeth Tullis; Sheelagh Martin; Mary Corey; Lap-Chee Tsui; Peter Durie
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

5.  Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype.

Authors:  V Dumur; R Gervais; J M Rigot; E Delomel-Vinner; B Decaestecker; J J Lafitte; P Roussel
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

6.  Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected.

Authors:  T Casals; L Bassas; J Ruiz-Romero; M Chillón; J Giménez; M D Ramos; G Tapia; H Narváez; V Nunes; X Estivill
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

7.  CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens.

Authors:  N Rave-Harel; I Madgar; R Goshen; M Nissim-Rafinia; A Ziadni; A Rahat; O Chiba; Y M Kalman; C Brautbar; D Levinson
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

Review 8.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

9.  Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients.

Authors:  B Mercier; C Verlingue; W Lissens; S J Silber; G Novelli; M Bonduelle; M P Audrézet; C Férec
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  CFTR variants and renal abnormalities in males with congenital unilateral absence of the vas deferens (CUAVD): a systematic review and meta-analysis of observational studies.

Authors:  Hongcai Cai; Xingrong Qing; Jean Damascene Niringiyumukiza; Xuxin Zhan; Dunsheng Mo; Yuanzhong Zhou; Xuejun Shang
Journal:  Genet Med       Date:  2018-09-14       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.